Objective:
To investigate effects of air transport and X-ray radiation exposure through airport security of a new room temperature-stable rFVIIa formulation (NovoSeven/NovoSeven RT, Novo Nordisk A/S, Bagsværd, Denmark
) lyophilized using
in vitro study methodology, thus evaluating possible effects of exposure through airport security and airplane travel.